Meril Defeats Edwards Lifesciences’ Patent Lawsuit on Appeal

March 25, 2024, 4:03 PM UTC

Indian medical device company Meril Inc. cemented its successful defense from rival artificial heart-valve maker Edwards Lifesciences Corp.'s patent infringement suit at the Federal Circuit.

Two of three judges on a panel for US Court of Appeals for the Federal Circuit on Monday agreed with a district court judge who granted Meril summary judgment that its Myval transcatheter heart-valve system doesn’t infringe Edwards’ patents.

Edwards sued Meril in 2019 a month after a Meril employee brought two sample Myval systems with him to the 2019 Transcatheter Cardiovascular Therapeutics Conference in San Francisco. Edwards argued that Meril took the devices to ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.